about
Nitrite-reductase and peroxynitrite isomerization activities of Methanosarcina acetivorans protoglobinThe Nutraceutical Properties of Ovotransferrin and Its Potential Utilization as a Functional FoodLactoferrin from Milk: Nutraceutical and Pharmacological PropertiesThe five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD studyIsoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin NLigand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albuminPhysiological roles of ovotransferrin.Cholesterol homeostasis failure in the brain: implications for synaptic dysfunction and cognitive decline.Cantharidin inhibits competitively heme-Fe(III) binding to the FA1 site of human serum albumin.Ac-tLeu-Asp-H is the minimal and highly effective human caspase-3 inhibitor: biological and in silico studies.Neuroglobin: From structure to function in health and disease.Role of glutathione transferases in the mechanism of brostallicin activation.Human caspase-3 inhibition by Z-tLeu-Asp-H: tLeu(P2) counterbalances Asp(P4) and Glu(P3) specific inhibitor truncation.Different disulfide bridge connectivity drives alternative folds in highly homologous Brassicaceae trypsin inhibitors.Structural Biology of Bacterial Haemophores.Ferric microperoxidase-11 catalyzes peroxynitrite isomerization.Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid.Human serum albumin: A modulator of cannabinoid drugs.Retinoic acid receptors: from molecular mechanisms to cancer therapy.Molecular phylogenetic analyses of albuminoids reveal the molecular evolution of allosteric propertiesThe Glu216/Ser218pocket is a major determinant of spermine oxidase substrate specificityHeme binding to albuminoid proteins is the result of recent evolutionCyanide binding to human plasma heme-hemopexin: a comparative study
P50
Q21132054-21BA5918-80BF-4A2B-81A9-0CCFDAEAE1FAQ26778137-A1301D51-7FA2-4319-AAAD-710086D02491Q28077296-D2EB19E0-89DB-487A-AAB0-3FB57236823AQ34083630-99407CF8-A9A4-4A10-829A-A863DAD9449FQ34924586-10392BC2-880F-4F5A-9F45-8879ACFEC3B5Q35581476-EE9D8A4B-C1A4-4958-8906-2CB60BEA2CA3Q37920019-28C69EAC-334E-4299-8E37-0817F3E61162Q38194244-8C7B2B44-725C-4842-8052-9217C685324FQ38728217-10819396-854E-46AF-B99B-72B9D4B080FBQ38946472-C75DA617-29FC-4634-BC3C-05796D2DDB78Q39003209-023FFA4F-7F9E-478D-B9B6-171F61746E5AQ39768792-CA1157F6-AD14-4A5D-B1BB-63A3D94644A7Q39929495-5D23BE90-772C-4068-8F75-05670F1C9D05Q40347620-C7AE87C9-DEB1-46C7-BC52-1066EB8FED65Q40890948-B0D0EDCB-D47A-4051-9056-044F3D32D924Q41595819-9E91B048-9B00-40D6-8A85-E5765302BE6BQ47598504-C9AF7479-7DC9-4D9D-B271-396775A49F52Q47701321-6D51AA38-12FE-43CB-BC1D-EE0D9507AC0EQ52656210-99683C36-D5D6-4318-B839-4BBBC2C379A6Q62141097-20B468AB-A78C-40FA-8791-8842B5DC3E6FQ62629888-D2FE9075-DB59-4EA7-88CE-A14CDD5D57E3Q80677183-CD143A69-7B81-40FF-B899-2D5E60CE9338Q87447419-6DD18C59-8A50-49A9-B1AF-2DF455A2075D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Loris Leboffe
@ast
Loris Leboffe
@en
Loris Leboffe
@es
Loris Leboffe
@nl
type
label
Loris Leboffe
@ast
Loris Leboffe
@en
Loris Leboffe
@es
Loris Leboffe
@nl
prefLabel
Loris Leboffe
@ast
Loris Leboffe
@en
Loris Leboffe
@es
Loris Leboffe
@nl
P106
P1153
17346421400
56953232200
P31
P496
0000-0001-8272-1896